DudeDiligence.

FINANCING

Who is raising money: selling new shares, filing room to sell more later, or borrowing. New shares give every holder a smaller slice.

Shares soldSold over timeRoom to sell laterBorrowingReverse splitThe stock since the filing

Key

Shares soldSold over timeRoom to sell laterBorrowingReverse splitThe stock since the filing

Newest first. A company with several filings is one row; open it for each.

  1. FATEFate Therapeutics, Inc.At-the-market programme, with Leerink Partners$100.0M89% of value−50.3%8-K ↗
  2. CYCUCycurion, Inc.Unregistered sale of shares, 8-K item 3.02size not available−29.9%8-K ↗
  3. RILYBRC Group Holdings, Inc.Notes$26.5M24% of value−25.9%8-K ↗
  4. MDWDMediWound Ltd.Public offering, 1.20M shares at $12.50$15.0M7.7% of value−4.3%424B5 ↗
  5. ENHAEnhanced Group Inc.Private placement$15.0M0.9% of value−14.5%8-K ↗
  6. SCYXSCYNEXIS, Inc.Shelf$200.0M−38.0%S-3 ↗
  7. AVTXAvalo Therapeutics, Inc.At-the-market programme$200.0M51% of value−4.4%
  8. ADGMAdagio Medical Holdings, Inc.Reverse split, 1-for-30−32.2%8-K ↗
  9. DDD3D Systems CorporationAt-the-market programme and private placement$42.5M17% of value−48.9%
  10. CLYMClimb Bio, Inc.Shelf, automatic (S-3ASR)no dollar limit−1.5%S-3ASR ↗
  11. UPWheels Up Experience Inc.Notes$390.0M−44.3%8-K ↗
  12. BIVIBioVie Inc.Public offering and at-the-market programme$6.5M75% of value−40.3%
  13. HYFMHydrofarm Holdings Group, Inc.Registered direct offeringsize not available−33.7%424B5 ↗
  14. YCBDcbdMD, Inc.Unregistered sale of shares, 8-K item 3.02size not available−11.3%8-K ↗
  15. FISNDeep Fission, Inc.Shelf$300.0M+31.2%S-3 ↗
  16. QNRXQuoin Pharmaceuticals, Ltd.At-the-market programme and public offering$11.0M70% of value−18.4%
  17. IVFINVO Fertility, Inc.Reverse split, 1-for-48-K ↗
  18. EVMNEvommune, Inc.Private placement, 4.97M shares$30.0M10% of value+16.6%8-K ↗
  19. FSTRL.B. Foster CompanyShelf$180.0M−8.7%S-3 ↗
  20. PODCPodcastOne, Inc.Private placement, 275K sharessize not available−16.7%8-K ↗
  21. DSGNDesign Therapeutics, Inc.Shelf and at-the-market programme$300.0M−15.1%
  22. VIVKVivakor, Inc.Unregistered sale of shares, 8-K item 3.02size not available−53.4%8-K ↗
  23. RACCResearch Alliance Corporation IIIPublic offeringsize not available−1.3%424B4 ↗
  24. NORDNordicus Partners CorporationUnregistered sale of shares, 8-K item 3.02size not available8-K ↗
  25. PSECProspect Capital CorporationNotessize not available−11.8%424B3 ↗
  26. LYELLyell Immunopharma, Inc.Private placement, 7.43M shares at $10.77$80.0M18% of value+28.1%8-K ↗
  27. CDTCDT Equity Inc.Reverse split, 1-for-20−82.8%8-K ↗
  28. AIREreAlpha Tech Corp.Public offering, 4.38M shares at $0.40$1.7M67% of value−9.7%424B4 ↗
  29. JSPRJasper Therapeutics, Inc.Reverse split, 1-for-30−39.7%8-K ↗
  30. GPATGP-Act III Acquisition Corp.Convertible notes and private placement$2.5M1.3% of value+3.6%
  31. BJDXBluejay Diagnostics, Inc.Reverse split, 1-for-4−23.1%8-K ↗
  32. BOSCB.O.S. Better Online Solutions Ltd.Shelf$10.0M−5.3%F-3 ↗
  33. ATXGAddentax Group Corp.Unregistered sale of shares, 8-K item 3.02size not available−13.7%8-K ↗
  34. GOVXGeoVax Labs, Inc.Registration for an offeringsize not available−54.0%S-1 ↗
  35. SWRDStewards Inc.Convertible notes and private placement$22.0M5.1% of value−38.3%
  36. FCHLFitness Champs Holdings LimitedRegistration for an offeringsize not available−98.0%F-1 ↗
  37. RWTRedwood Trust, Inc.Reverse split and private placement−14.1%
  38. RMTIRockwell Medical, Inc.Convertible notes and private placement$100.0M4.3x value−28.1%
  39. IMSRTerrestrial Energy Inc.Shelf$500.0M−24.5%S-3 ↗